Suggestions for regulatory agency approval of second-line systemic therapy for metastatic transitional cell carcinoma Letter uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Phytogenic
  • Antineoplastic Combined Chemotherapy Protocols
  • Carcinoma, Transitional Cell
  • Drug Approval
  • Urologic Neoplasms
  • Vinblastine

publication date

  • May 2010

Research

keywords

  • Letter

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2009.27.1114

PubMed ID

  • 20159797

Additional Document Info

start page

  • e205

end page

  • 7; author reply e208

volume

  • 28

number

  • 13